Generated on March 20 2026 07:16 AM
Old data? UPDATE !
The score is 54/100
Title
CLL Society, the Leading Authority for CLL and SLL Patients
Length : 59
Perfect, your title contains between 10 and 70 characters.
Description
CLL Society is devoted to serving chronic lymphocytic leukemia and small lymphocytic lymphoma cancer patients and caregivers through support and education.
Length : 155
Great, your meta description contains between 70 and 160 characters.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| locale | en_US |
| type | website |
| title | Get the Best Care for Your Chronic Lymphocytic Leukemia - CLL Society |
| description | Addressing the unmet needs of the Chronic Lymphocytic Leukemia (CLL) community, our goal is to provide recent and relevant information for CLL patients. |
| url | https://cllsociety.org/ |
| site_name | CLL Society |
| image | https://cllsociety.org/wp-content/uploads/2022/04/CLL-Society-LOGO-w_Tag_Neon_Letter_cropped-300x226-1.png |
| image:width | 300 |
| image:height | 226 |
| image:type | image/png |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 12 | 6 | 3 | 5 | 0 |
Images
We found 30 images on this web page.
19 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.
Text/HTML Ratio
Ratio : 4%
This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.
In-page links
We found a total of 104 links including 1 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Skip to content | Internal | Passing Juice |
| HOME | Internal | Passing Juice |
| What’s New | Internal | Passing Juice |
| Info & Mgmt | Internal | Passing Juice |
| Newly Diagnosed | Internal | Passing Juice |
| CLL / SLL Patient Education Toolkit | Internal | Passing Juice |
| Watch and Wait | Internal | Passing Juice |
| Build Your Care Team | Internal | Passing Juice |
| CLL Doctors | Internal | Passing Juice |
| CLL / SLL Symptoms | Internal | Passing Juice |
| Basic Biology of CLL | Internal | Passing Juice |
| Staging | Internal | Passing Juice |
| Complications | Internal | Passing Juice |
| CLL Testing & Imaging | Internal | Passing Juice |
| CLL Diagnosis | Internal | Passing Juice |
| Test Before Treat™ | Internal | Passing Juice |
| Treatment and Research | Internal | Passing Juice |
| Indications for Treatment | Internal | Passing Juice |
| CLL Medicine Cabinet | Internal | Passing Juice |
| Clinical Trials | Internal | Passing Juice |
| Clinical Trial Basics | Internal | Passing Juice |
| Opening Trials & Status Updates | Internal | Passing Juice |
| Clinical Trial Results | Internal | Passing Juice |
| The Patient Perspective | Internal | Passing Juice |
| Targeted Therapies | Internal | Passing Juice |
| Immunotherapy | Internal | Passing Juice |
| Chemotherapy | Internal | Passing Juice |
| CAR-T and Other Cellular Therapies | Internal | Passing Juice |
| Frontline Therapies | Internal | Passing Juice |
| Relapsed/Refractory or Later Therapies | Internal | Passing Juice |
| Richter’s Transformation | Internal | Passing Juice |
| MRD and Disease Monitoring | Internal | Passing Juice |
| CLL / SLL Resources | Internal | Passing Juice |
| Normal CLL Lab Values | Internal | Passing Juice |
| Keeping Track of Lab Results | Internal | Passing Juice |
| CLL Glossary | Internal | Passing Juice |
| CLL Abbreviations & Acronyms | Internal | Passing Juice |
| Ask the Experts | Internal | Passing Juice |
| Health Equity in CLL | Internal | Passing Juice |
| Opinions and Insights | Internal | Passing Juice |
| Regulatory News | Internal | Passing Juice |
| Programs & Support | Internal | Passing Juice |
| Support Groups | Internal | Passing Juice |
| 1-on-1 Support Programs | Internal | Passing Juice |
| Upcoming Events | Internal | Passing Juice |
| Expert Access™ | Internal | Passing Juice |
| Education On-Demand | Internal | Passing Juice |
| CareCast Podcast | Internal | Passing Juice |
| COVID-19 | Internal | Passing Juice |
| COVID-19 Action Plan | Internal | Passing Juice |
| COVID-19 Updates | Internal | Passing Juice |
| COVID-19 Prevention & Treatment | Internal | Passing Juice |
| COVID-19 Official Statements | Internal | Passing Juice |
| COVID-19 Virtual Community Meetings | Internal | Passing Juice |
| COVID-19 General Information | Internal | Passing Juice |
| Living With CLL | Internal | Passing Juice |
| Stories and Testimonials | Internal | Passing Juice |
| Financial Resources | Internal | Passing Juice |
| Insurance Resources | Internal | Passing Juice |
| Mental and Physical Health | Internal | Passing Juice |
| Dr. Koffman’s Blogs | Internal | Passing Juice |
| Creative Corner | Internal | Passing Juice |
| Being Your Own Advocate | Internal | Passing Juice |
| Care Partners | Internal | Passing Juice |
| Veterans | Internal | Passing Juice |
| End of Life Planning | Internal | Passing Juice |
| Surveys | Internal | Passing Juice |
| About Us | Internal | Passing Juice |
| CLL Society in the News | Internal | Passing Juice |
| Our Story, Mission, and Vision | Internal | Passing Juice |
| Scientific Publications | Internal | Passing Juice |
| Board of Directors | Internal | Passing Juice |
| Medical Advisory Board | Internal | Passing Juice |
| Expert Medical Council | Internal | Passing Juice |
| International Partners | Internal | Passing Juice |
| Special Contributors | Internal | Passing Juice |
| Patient Advisory Board | Internal | Passing Juice |
| CLL Society Staff | Internal | Passing Juice |
| Volunteers | Internal | Passing Juice |
| Contact Us | Internal | Passing Juice |
| CLL Society Industry Advisory Council | Internal | Passing Juice |
| Research | Internal | Passing Juice |
| Current Funding Opportunities | Internal | Passing Juice |
| Apply for a Grant | Internal | Passing Juice |
| Eligibility | Internal | Passing Juice |
| Selection and Review Process | Internal | Passing Juice |
| Research Program Guidelines | Internal | Passing Juice |
| What We Fund | Internal | Passing Juice |
| Support Our Efforts | Internal | Passing Juice |
| Advocacy | Internal | Passing Juice |
| Needs of the Immunocompromised | Internal | Passing Juice |
| Access | Internal | Passing Juice |
| Innovation | Internal | Passing Juice |
| Donate | Internal | Passing Juice |
| Community Fundraising | Internal | Passing Juice |
| Celebrating Long Lives 5K Event | External | Passing Juice |
| Legacy Giving | Internal | Passing Juice |
| From Diagnosis to Advocacy: Albie Suozzi’s CLL Journey Featured on the Cover of Cancer Health | Internal | Passing Juice |
| Meet a New More Dangerous Doctor than Dr. Google: AI | Internal | Passing Juice |
| Golf, 25 Years of CLL, and Long Remissions | Internal | Passing Juice |
| CLL Patients are Immunocompromised, But What Does That Mean? | Internal | Passing Juice |
| FDA Approves Combo of Acalabrutinib and Venetoclax in CLL | Internal | Passing Juice |
| Epcoritamab Combination Therapies for Richter Transformation | Internal | Passing Juice |
| Site Design | External | Passing Juice |
Keywords Cloud
treatment cookies covid-19 clinical research support cll cookie sll resources
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| cll | 106 | ![]() |
![]() |
![]() |
![]() |
| covid-19 | 28 | ![]() |
![]() |
![]() |
![]() |
| cookies | 24 | ![]() |
![]() |
![]() |
![]() |
| sll | 22 | ![]() |
![]() |
![]() |
![]() |
| research | 22 | ![]() |
![]() |
![]() |
![]() |
Url
Domain : cllsociety.org
Length : 14
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
![]() |
Excellent, your website doesn't use nested tables. |
![]() |
Too bad, your website is using inline styles. |
![]() |
Great, your website has few CSS files. |
![]() |
Too bad, your website has too many JS files (more than 6). |
![]() |
Perfect, your website takes advantage of gzip. |
Mobile Optimization
![]() |
Apple Icon |
![]() |
Meta Viewport Tag |
![]() |
Flash content |
XML Sitemap
Great, your website has an XML sitemap.
| https://cllsociety.org/sitemap_index.xml |
Robots.txt
https://cllsociety.org/robots.txt
Great, your website has a robots.txt file.
Analytics
Great, your website has an analytics tool.
Google Analytics |
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.